Skip to main content

Table 2 Treatment by nutlin-3 results in a concentration dependent increase of the number of p53 positive cells as well as of the staining intensity as revealed by immunohistochemistry.

From: Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium

#case

treatment

duration of treatment

number of p53-positive cells

intensity

percentage of Ki67-positive cells

0694-2

control

 

11

0 - 1

n.d.

 

10 μM nutlin-3

72 h

393

2

n.d.

 

30 μM nutlin-3

 

1, 277

3

n.d.

0695-0

control

 

0

0

4%

 

10 μM nutlin-3

 

11

1

< 1%

 

30 μM nutlin-3

 

188

1

< 1%

0695-1

control

 

0

0

-

 

10 μM nutlin-3

 

42

0 - 1

-

 

30 μM nutlin-3

6 days

89

1

-

0695-2

control

 

0

0

< 1%

 

10 μM nutlin-3

 

194

1 - 2

-

 

30 μM nutlin-3

 

799

3

-

0695-3

control

 

0

0

< 1%

 

10 μM nutlin-3

 

770

3

 
 

30 μM nutlin-3

 

1, 493

3

 

0687-0

control

 

0

0

n.d.

 

10 μM nutlin-3

 

2

1

n.d.

 

30 μM nutlin-3

72 h

257

2

n.d.

0687-1

control

 

0

0

n.d.

 

10 μM nutlin-3

 

398

2

n.d.

 

30 μM nutlin-3

 

n.d.

n.d.

n.d.

  1. For further information of the tumors studied (karyotype, age, tumor size) see Table 1.